During this presentation and webcast, we welcome Kiora Pharmaceuticals, ticker symbol of KPRX on the NASDAQ. And joining us today from the company is Brian Strem. Brian is the company’s Chief Executive Officer, and we also have Melissa Tosca, the company’s EVP of Finance.

Kiora Pharmaceuticals is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases.

This Company Webcast was recorded during the Lytham Partners Spring 2024 Investor Conference.